Pfizer Total Assets decreased by 0.3% to $207.62B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.2%, from $208.03B to $207.62B. Over 5 years (FY 2020 to FY 2025), Total Assets shows an upward trend with a 6.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Growth generally indicates business expansion, while a decline may suggest asset liquidation or a contraction in business scale.
This is the sum of all current and non-current assets owned by the company, representing the total resource base availab...
Universal financial metric used by all public companies to define the size of the balance sheet.
total_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $169.92B | $179.19B | $181.48B | $183.84B | $195.29B | $195.35B | $197.21B | $195.62B | $220.17B | $215.02B | $226.50B | $221.10B | $216.19B | $219.48B | $213.40B | $208.03B | $206.10B | $208.73B | $208.16B | $207.62B |
| QoQ Change | — | +5.5% | +1.3% | +1.3% | +6.2% | +0.0% | +0.9% | -0.8% | +12.6% | -2.3% | +5.3% | -2.4% | -2.2% | +1.5% | -2.8% | -2.5% | -0.9% | +1.3% | -0.3% | -0.3% |
| YoY Change | — | — | — | — | +14.9% | +9.0% | +8.7% | +6.4% | +12.7% | +10.1% | +14.9% | +13.0% | -1.8% | +2.1% | -5.8% | -5.9% | -4.7% | -4.9% | -2.5% | -0.2% |